Black patients with cancer fare worse with COVID-19, study shows

April 1, 2022

Structural racism, rather than disease, leads to inequities, authors write Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of the COVID-19 and Cancer Consortium (https://ccc19.org/), which includes more than 125 cancer centers and other organizations, studied […]




Department of Biochemistry and Structural Biology assistant professor earns UT System Rising STARs award to further metabolic disease research

April 1, 2022

Kevin Koronowski, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine and the Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, received a UT System Rising STARs (Science and Technology Acquisition and Retention) award in […]


Noted cancer researcher receives UT System Faculty STARs award

April 1, 2022

Daohong Zhou, MD, a professor with tenure in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has received a UT System Faculty STARs award in the amount of $1,487,563 to support his drug discovery research.

Star trophy with blue background.



Reuben Harris, PhD, to chair Department of Biochemistry and Structural Biology

March 17, 2022

Cancer and virology researcher Reuben Harris, PhD, has been named chairman of the Department of Biochemistry and Structural Biology at UT Health San Antonio. The department is in the Joe R. and Teresa Lozano Long School of Medicine. Dr. Harris, a professor with tenure, will assume his duties effective April 11, 2022, announced Robert Hromas, […]

Concept art of a microscope


Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

March 10, 2022

An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]